dehydroepiandrosterone and Colitis, Granulomatous studies

dehydroepiandrosterone and Colitis, Granulomatous

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Research Excerpts

Excerpt	Relevance	Reference
"Treatment with dehydroepiandrosterone was effective in randomized controlled trials in patients with systemic lupus erythematosus."	2.71	Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. ( Andus, T; Bregenzer, N; Klebl, F; Rogler, G; Schölmerich, J; Straub, RH, 2003)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

1 (50.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Andus, T	1
Klebl, F	1
Rogler, G	1
Bregenzer, N	1
Schölmerich, J	1
Straub, RH	1
Osathanondh, R	1
Fencl, MD	1
Schiff, I	1
Himmel, M	1
Tulchinsky, D	1

Studies

Andus, T

Klebl, F

Rogler, G

Bregenzer, N

Schölmerich, J

Straub, RH

Osathanondh, R

Fencl, MD

Schiff, I

Himmel, M

Tulchinsky, D

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Randomized, Double-Blind, Multi-Center, Dose Response, Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Moderately Active Crohn's Disease[NCT00106314]	Phase 2	75 participants	Interventional	2005-01-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

A Randomized, Double-Blind, Multi-Center, Dose Response, Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Moderately Active Crohn's Disease[NCT00106314]

Phase 2

75 participants

Interventional

2005-01-31

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for dehydroepiandrosterone and Colitis, Granulomatous

Article	Year
Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:3 Topics: Adjuvants, Immunologic; Adult; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Dehydroepiandros	2003

Article

Year

Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study.

Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:3

Topics: Adjuvants, Immunologic; Adult; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Dehydroepiandros

2003

Other Studies

1 other study available for dehydroepiandrosterone and Colitis, Granulomatous

Article	Year
Reduced urinary and serum total estriol levels in pregnancies after colectomy. Obstetrics and gynecology, 1979, Volume: 53, Issue:5 Topics: Adrenal Glands; Adult; Colectomy; Colitis, Ulcerative; Crohn Disease; Dehydroepiandrosterone; Entero	1979

Article

Year

Reduced urinary and serum total estriol levels in pregnancies after colectomy.

Obstetrics and gynecology, 1979, Volume: 53, Issue:5

Topics: Adrenal Glands; Adult; Colectomy; Colitis, Ulcerative; Crohn Disease; Dehydroepiandrosterone; Entero

1979